Exagen EV - Enterprise Value 2011-2026 | XGN

Annual EV - Enterprise Value Exagen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.4 M	72.3 M	29 M	21.7 M	60.5 M	178 M	41.1 M	22.4 M	25 M	-	36.8 M	31.2 M	16 M	6.44 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
178 M	6.44 M	47.6 M

EV - Enterprise Value of other stocks in the Diagnostics research industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Akumin AKU	1.64 B	-	-17.87 %	$ 25.9 M	Canada
Centogene N.V. CNTG	-19.1 M	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	433 M	$ 16.65	-	$ 179 M	China
Agilent Technologies A	45.8 B	$ 113.98	-0.78 %	$ 34.6 B	USA
Accelerate Diagnostics AXDX	92.6 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	10.6 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	15 M	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	39.2 M	-	0.22 %	$ 16.8 M	USA
Castle Biosciences CSTL	665 M	$ 24.15	-2.23 %	$ 671 M	USA
Check-Cap Ltd. CHEK	2.55 M	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	-1.92 M	$ 1.61	-1.21 %	$ 2.14 M	USA
CareDx, Inc CDNA	1.04 B	$ 22.01	0.43 %	$ 1.17 B	USA
Oxford Immunotec Global PLC OXFD	26.2 M	-	-	$ 562 M	Britain
DermTech DMTK	70.4 M	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	-22.7 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	22 B	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	502 M	$ 15.24	-0.39 %	$ 461 M	USA
Illumina ILMN	15.3 B	$ 125.07	-1.46 %	$ 19.9 B	USA
Global Cord Blood Corporation CO	-2.77 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	6.64 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	9.21 B	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	251 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	11.4 B	$ 167.08	0.22 %	$ 8.28 B	USA
PRA Health Sciences, Inc. PRAH	5.02 B	-	-	$ 10.7 B	USA
HTG Molecular Diagnostics HTGM	3.16 M	-	-20.0 %	$ 1.06 M	USA
Guardant Health GH	15.2 B	$ 82.63	-0.59 %	$ 10.4 B	USA
Lantheus Holdings LNTH	5.9 B	$ 82.9	-0.78 %	$ 5.59 B	USA
Heska Corporation HSKA	851 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	16.3 M	$ 1.93	-	$ 8.54 M	USA
Koninklijke Philips N.V. PHG	13.2 B	$ 25.77	-5.03 %	$ 20 B	Niderland
Personalis PSNL	229 M	$ 5.34	-2.92 %	$ 316 M	USA
Senseonics Holdings SENS	376 M	$ 7.03	-2.09 %	$ 293 M	USA
QIAGEN N.V. QGEN	11.3 B	-	-	$ 10.6 B	Niderland
Medpace Holdings MEDP	14 B	$ 403.62	-1.5 %	$ 11.6 B	USA
Biomerica BMRA	6.63 M	$ 2.18	-0.46 %	$ 5.01 M	USA
Motus GI Holdings MOTS	568 K	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	26.4 B	$ 111.86	9.14 %	$ 9.23 B	Irlanda
Laboratory Corporation of America Holdings LH	33.1 B	$ 260.29	0.29 %	$ 21.7 B	USA
Trinity Biotech plc TRIB	133 M	$ 0.61	-0.23 %	$ 61.9 M	Irlanda
NeoGenomics NEO	1.85 B	$ 9.6	6.43 %	$ 1.23 B	USA
Twist Bioscience Corporation TWST	1.55 B	$ 57.42	-2.92 %	$ 3.43 B	USA
Celcuity CELC	5.57 B	$ 118.83	-1.04 %	$ 5.56 B	USA
Neogen Corporation NEOG	2.26 B	$ 9.19	-1.61 %	$ 1.99 B	USA
National Research Corporation NRC	432 M	$ 15.88	-5.7 %	$ 355 M	USA
Myriad Genetics MYGN	598 M	$ 4.77	-1.45 %	$ 442 M	USA
Natera NTRA	5.53 B	$ 196.02	-2.08 %	$ 19.3 B	USA
Quest Diagnostics Incorporated DGX	22.9 B	$ 192.19	-1.43 %	$ 21.3 B	USA
Invitae Corporation NVTA	2.11 B	-	-	$ 21.2 M	USA
OpGen OPGN	10.3 M	-	-16.95 %	$ 1.54 M	USA